PBH (Prestige Consumer Healthcare) PE Ratio: 12.35 (As of Jul. 09, 2026) — 21% Below Median


PBH Prestige Consumer Healthcare Inc PBH
68 GF Score
Price $48.29
GF Value $68.39
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Prestige Consumer Healthcare PE Ratio?

Prestige Consumer Healthcare PBH -4.22% 68 PE Ratio is 12.35 as of Jul. 09, 2026, which is 21% below its 10-year median of 15.56. GuruFocus rates PBH with a GF Score™ of 68/100 and a GF Value™ of $68.39 (Modestly Undervalued). The stock has 4 warning signs investors should review.

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2026-07-09), Prestige Consumer Healthcare's share price is $48.29. Prestige Consumer Healthcare's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $3.91. Therefore, Prestige Consumer Healthcare's PE Ratio for today is 12.35.

Good Sign:

Prestige Consumer Healthcare Inc stock PE Ratio (=12.9) is close to 5-year low of 11.96.

During the past 13 years, Prestige Consumer Healthcare's highest PE Ratio was 44.16. The lowest was 4.55. And the median was 15.56.

Prestige Consumer Healthcare's EPS (Diluted) for the three months ended in Mar. 2026 was $1.13. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $3.91.

As of today (2026-07-09), Prestige Consumer Healthcare's share price is $48.29. Prestige Consumer Healthcare's EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 was $4.01. Therefore, Prestige Consumer Healthcare's PE Ratio without NRI ratio for today is 12.04.

During the past 13 years, Prestige Consumer Healthcare's highest PE Ratio without NRI was 29.84. The lowest was 3.71. And the median was 14.50.

Prestige Consumer Healthcare's EPS without NRI for the three months ended in Mar. 2026 was $1.23. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 was $4.01.

During the past 12 months, Prestige Consumer Healthcare's average EPS without NRI Growth Rate was -3.10% per year. During the past 3 years, the average EPS without NRI Growth Rate was 1.30% per year. During the past 5 years, the average EPS without NRI Growth Rate was 5.40% per year. During the past 10 years, the average EPS without NRI Growth Rate was 6.00% per year.

During the past 13 years, Prestige Consumer Healthcare's highest 3-Year average EPS without NRI Growth Rate was 230.20% per year. The lowest was -40.10% per year. And the median was 11.20% per year.

Prestige Consumer Healthcare's EPS (Basic) for the three months ended in Mar. 2026 was $1.14. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was $3.94.

Back to Basics: PE Ratio


Prestige Consumer Healthcare  (NYSE:PBH) PE Ratio Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio without NRI or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratios are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.

PE Ratio can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio.


Prestige Consumer Healthcare PE Ratio Related Terms


Prestige Consumer Healthcare PE Ratio Historical Data

* Premium members only.

The historical data trend for Prestige Consumer Healthcare's PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Prestige Consumer Healthcare PE Ratio Chart

Prestige Consumer Healthcare Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.10 At Loss 17.40 20.04 15.16

Prestige Consumer Healthcare Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.04 18.74 15.48 16.32 15.16

PBH vs BCRX, AMLX, SUPN: PE Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Prestige Consumer Healthcare's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Prestige Consumer Healthcare PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Prestige Consumer Healthcare's PE Ratio distribution charts can be found below:

* The bar in red indicates where Prestige Consumer Healthcare's PE Ratio falls into.


PBH
68GF Score
Prestige Consumer Healthcare Inc PBH
PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Prestige Consumer Healthcare PE Ratio Calculation

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.

Prestige Consumer Healthcare's PE Ratio for today is calculated as

PE Ratio=Share Price/Earnings per Share (Diluted) (TTM)
=48.29/3.910
=12.35

Prestige Consumer Healthcare's Share Price of today is $48.29.
Prestige Consumer Healthcare's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.91.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:


There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the calculation of PE Ratio, the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.

Frequently Asked Questions Learn more about PE Ratio →
What does a PE Ratio of 12.35 mean?
Prestige Consumer Healthcare (PBH) has a PE Ratio of 12.35 as of Jul. 09, 2026. P/E ratio is the ratio of share price to a company's earnings per share. View historical data on Prestige Consumer Healthcare and its competitors. This is 21% below median its historical median of 15.56. Over the past decade, Prestige Consumer Healthcare's PE Ratio has ranged from 4.55 to 44.16.
Is Prestige Consumer Healthcare's PE Ratio too high?
Prestige Consumer Healthcare's current PE Ratio of 12.35 is 21% below median its 10-year median of 15.56. Over the past 10 years, this metric has ranged from a low of 4.55 to a high of 44.16. Overall, Prestige Consumer Healthcare has a GF Score™ of 68/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Prestige Consumer Healthcare's PE Ratio compare to BCRX and AMLX?
Prestige Consumer Healthcare's PE Ratio of 12.35 can be compared against companies in the Drug Manufacturers industry. Historically, Prestige Consumer Healthcare's own PE Ratio has ranged from 4.55 to 44.16 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio for a Drug Manufacturers company?
A good PE Ratio depends on the Drug Manufacturers industry context. However, PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio mean?
A high PE Ratio can signal that a stock is expensive relative to its fundamentals. P/E ratio is the ratio of share price to a company's earnings per share. View historical data on Prestige Consumer Healthcare and its competitors. Prestige Consumer Healthcare's current PE Ratio is 12.35, which is 21% below median its own 10-year median of 15.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Prestige Consumer Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Prestige Consumer Healthcare (PBH) is currently considered Modestly Undervalued. The stock's GF Value™ is $68.39, compared to a current price of $48.29 — trading 29.4% below its estimated fair value. The current PE Ratio is 12.35, which is 21% below median its 10-year median of 15.56. Prestige Consumer Healthcare's overall GF Score™ is 68/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio calculated?
PE Ratio is calculated from a company's financial statements. For Prestige Consumer Healthcare (PBH), the current PE Ratio is 12.35 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Prestige Consumer Healthcare (PBH) Overvalued in 2026?

Based on GuruFocus' analysis, Prestige Consumer Healthcare stock appears to be undervalued. The current stock price of $48.29 is trading 29.4% below its estimated GF Value™ of $68.39. GuruFocus considers Prestige Consumer Healthcare to be Modestly Undervalued.

Key valuation signals for PBH:

  • PE Ratio: 12.35 (21% below median its 10-year median of 15.56)
  • GF Value™: $68.39 vs. price of $48.29 (29.4% below fair value)
  • GF Score™: 68/100 with 4 warning signs

No single metric tells the full story. See the PBH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Prestige Consumer Healthcare Business Description

Other Exchanges PBV:Germany
Address 660 White Plains Road, Tarrytown, NY, USA, 10591
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
68GF Score

Get the complete analysis for PBH

PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$48.29
Price
$68.39
GF Value